Evidence map›Paper›PMID 35496495›Full record

ArticleData in brief2022

RNA-seq datasets of field soybean cultures conditioned by Elice16Indures® biostimulator.

Kincső Decsi, Barbara Kutasy, Márta Kiniczky, Géza Hegedűs, Eszter Virág

Abstract read
In one paragraph

Article in Data in brief, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kincső DecsiDepartment of Plant Physiology and Plant Ecology, Hungarian University of Agriculture and Life Sciences, Georgikon Campus Keszthely, Festetics Gy. u.7., Keszthely 8360, Hungary.
Barbara KutasyDepartment of Plant Physiology and Plant Ecology, Hungarian University of Agriculture and Life Sciences, Georgikon Campus Keszthely, Festetics Gy. u.7., Keszthely 8360, Hungary.
Márta KiniczkyResearch Institute for Medicinal Plants and Herbs Ltd., 2011 Budakalász, Lupaszigeti út 4., Hungary.
Géza HegedűsEduCoMat Ltd., Iskola u. 12/A., Keszthely 8360, Hungary.
Eszter VirágEduCoMat Ltd., Iskola u. 12/A., Keszthely 8360, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The herbal drug-containing plant conditioner Elice16Indures® may help elicit plant immune responses in field dicotyledonous cultures. Application of this conditioner is also allowed in organic farming and recommended its drone spraying application in small doses. In this way, even distribution and better yields may be reached leading to economical and safe plant growing. The high protein content soy is an important food both in animal and human aspects which ecological cultivation is gaining prominence over GMO technology in the European Union. We present RNA-seq datasets of control and Elice16Indures treated soybean plants cultivated in field conditions from 01/05/2020 to 20/07/2020. For RNA seq experiments six samples were collected from vegetative tissues two times during the vegetation cycle: before and in flowering after 48 h of drone exposure. The 86 bp long Illumina NextSeq 550 reads were preprocessed and deposited in the NCBI SRA database. De novo assembly of combined read sets was performed and transcripts were deposited in the NCBI TSA database. Data of functional analysis of annotated transcripts are presented. The SRA and TSA datasets are under the Bioproject accession PRJNA778970. The presented datasets may help new strategies of ecological production of soy.

Indexed as

Glycine maxIllumina sequencingOrganic farmingPlant conditionerRNA-seqSoybeanTranscriptome

Identifiers

PMID35496495
PMCPMC9046642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.